Bile Acid at Low pH Reduces Squamous Differentiation and Activates EGFR Signaling in Esophageal Squamous Cells in 3-D Culture

Journal of Gastrointestinal Surgery

Volumn 17, Issue 10, 2013, Pages 1723-1731

  Ghatak, Sayak ^a   Reveiller, Marie ^b   Toia, Liana ^d   Ivanov, Andrei ^c   Godfrey, Tony E ^d   Peters, Jeffrey H ^d  

^a UNIVERSITY OF ROCHESTER   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Barrett's esophagus; Bile acid; Squamous down regulation; Transwell culture

Indexed keywords

BILE ACID; EGFR PROTEIN, HUMAN; EPIDERMAL GROWTH FACTOR RECEPTOR;

ARTICLE; CELL DIFFERENTIATION; CULTURE TECHNIQUE; DRUG EFFECT; EPITHELIUM; EPITHELIUM CELL; ESOPHAGUS; HUMAN; METHODOLOGY; PATHOLOGY; PH; PHYSIOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL CULTURE;

BILE ACIDS AND SALTS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; EPITHELIAL CELLS; EPITHELIUM; ESOPHAGUS; HUMANS; HYDROGEN-ION CONCENTRATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 84884675980     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-013-2287-1     Document Type: Article

References (46)

1. Parkin, D. M., et al., Global cancer statistics, 2002. CA Cancer J Clin, 2005. 55(2): p. 74-108.
2. Souza, R. F., K. Krishnan, and S. J. Spechler, Acid, bile, and CDX: the ABCs of making Barrett's metaplasia. Am J Physiol Gastrointest Liver Physiol, 2008. 295(2): p. G211-8.
3. Modiano, N. and L. B. Gerson, Barrett's esophagus: incidence, etiology, pathophysiology, prevention and treatment. Ther Clin Risk Manag, 2007. 3(6): p. 1035-145.
4. Herfs, M., P. Hubert, and P. Delvenne, Epithelial metaplasia: adult stem cell reprogramming and (pre)neoplastic transformation mediated by inflammation? Trends Mol Med, 2009. 15(6): p. 245-53.
5. Reveiller, M., et al., Bile exposure inhibits expression of squamous differentiation genes in human esophageal epithelial cells. Ann Surg, 2012. 255(6): p. 1113-1120.
6. Werner, S. and R. Grose, Regulation of wound healing by growth factors and cytokines. Physiol Rev, 2003. 83(3): p. 835-70.
7. Hallman, M. A., S. Zhuang, and R. G. Schnellmann, Regulation of dedifferentiation and redifferentiation in renal proximal tubular cells by the epidermal growth factor receptor. J Pharmacol Exp Ther, 2008. 325(2): p. 520-8.
8. Orlando, L. A. and R. C. Orlando, Dilated intercellular spaces as a marker of GERD. Curr Gastroenterol Rep, 2009. 11(3): p. 190-4.
9. Avissar, N. E., et al., Bile acid alone, or in combination with acid, induces CDX2 expression through activation of the epidermal growth factor receptor (EGFR). J Gastrointest Surg, 2009. 13(2): p. 212-22.
10. Harada, H., et al., Telomerase induces immortalization of human esophageal keratinocytes without p16INK4a inactivation. Mol Cancer Res, 2003. 1(10): p. 729-38.
11. Deyrieux, A. F. and V. G. Wilson, In vitro culture conditions to study keratinocyte differentiation using the HaCaT cell line. Cytotechnology, 2007. 54(2): p. 77-83.
12. Liu, T., et al., Regulation of Cdx2 expression by promoter methylation, and effects of Cdx2 transfection on morphology and gene expression of human esophageal epithelial cells. Carcinogenesis, 2007. 28(2): p. 488-96.
13. Engelman, J. A., et al., PF00299804, an irreversible pan-ERBB inhibitor, is effective in lung cancer models with EGFR and ERBB2 mutations that are resistant to gefitinib. Cancer Research, 2007. 67(24): p. 11924-11932.
14. Ou, S. H., Second-generation irreversible epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs): a better mousetrap? A review of the clinical evidence. Crit Rev Oncol Hematol, 2012. 83(3): p. 407-21.
15. Yoon, H. H., et al., Association of HER2/ErbB2 expression and gene amplification with pathologic features and prognosis in esophageal adenocarcinomas. Clin Cancer Res, 2012. 18(2): p. 546-54.
16. Kotewicz, M. L., et al., Cloning and overexpression of Moloney murine leukemia virus reverse transcriptase in Escherichia coli. Gene, 1985. 35(3): p. 249-58.
17. Tassone, F., et al., Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome. Am J Hum Genet, 2000. 66(1): p. 6-15.
18. Seery, J. P. and F. M. Watt, Asymmetric stem-cell divisions define the architecture of human oesophageal epithelium. Curr Biol, 2000. 10(22): p. 1447-50.
19. Paulson, T. G., et al., Neosquamous epithelium does not typically arise from Barrett's epithelium. Clinical Cancer Research, 2006. 12(6): p. 1701-1706.
20. Wang, X., et al., Residual embryonic cells as precursors of a Barrett's-like metaplasia. Cell, 2011. 145(7): p. 1023-1035.
21. Quante, M., et al., Bile acid and inflammation activate gastric cardia stem cells in a mouse model of Barrett-like metaplasia. Cancer Cell, 2012. 21(1): p. 36-51.
22. Wolfsen, H. C., L. L. Hemminger, and K. R. DeVault, Recurrent Barrett's esophagus and adenocarcinoma after esophagectomy. BMC Gastroenterol, 2004. 4: p. 18.
23. Hu, Y., et al., The pathogenesis of Barrett's esophagus: secondary bile acids upregulate intestinal differentiation factor CDX2 expression in esophageal cells. J Gastrointest Surg, 2007. 11(7): p. 827-34.
24. Kalabis, J., et al., A subpopulation of mouse esophageal basal cells has properties of stem cells with the capacity for self-renewal and lineage specification. Journal of Clinical Investigation, 2008. 118(12): p. 3860-3869.
25. Kalabis, J., et al., Isolation and characterization of mouse and human esophageal epithelial cells in 3D organotypic culture. Nat Protoc, 2012. 7(2): p. 235-46.
26. Atanassoff, P. G., et al., The time course of gastric pH changes induced by omeprazole and ranitidine: a 24-hour dose-response study. Anesth Analg, 1995. 80(5): p. 975-9.
27. Dehn, T. C., et al., Double blind comparison of omeprazole (40 mg od) versus cimetidine (400 mg qd) in the treatment of symptomatic erosive reflux oesophagitis, assessed endoscopically, histologically and by 24 h pH monitoring. Gut, 1990. 31(5): p. 509-13.
28. Kauer, W. K., et al., Composition and concentration of bile acid reflux into the esophagus of patients with gastroesophageal reflux disease. Surgery, 1997. 122(5): p. 874-81.
29. 2+ ions. J Lipid Res, 1992. 33(5): p. 617-26.
30. Williams, C., Occurrence and significance of gastric colonization during acid-inhibitory therapy. Best Pract Res Clin Gastroenterol, 2001. 15(3): p. 511-21.
31. DeMeester, T. R., Clinical biology of the Barrett's metaplasia, dysplasia to carcinoma sequence. Surg Oncol, 2001. 10(3): p. 91-102.
32. Theisen, J., et al., Suppression of gastric acid secretion in patients with gastroesophageal reflux disease results in gastric bacterial overgrowth and deconjugation of bile acids. J Gastrointest Surg, 2000. 4(1): p. 50-4.
33. Dvorak, K., et al., Expression of bile acid transporting proteins in Barrett's esophagus and esophageal adenocarcinoma. Am J Gastroenterol, 2009. 104(2): p. 302-9.
34. Yasuda, H., et al., Involvement of membrane-type bile acid receptor M-BAR/TGR5 in bile acid-induced activation of epidermal growth factor receptor and mitogen-activated protein kinases in gastric carcinoma cells. Biochem Biophys Res Commun, 2007. 354(1): p. 154-9.
35. Araki, Y., et al., Bile acid modulates transepithelial permeability via the generation of reactive oxygen species in the Caco-2 cell line. Free Radic Biol Med, 2005. 39(6): p. 769-80.
36. Feagins, L. A., et al., Mechanisms of oxidant production in esophageal squamous cell and Barrett's cell lines. Am J Physiol Gastrointest Liver Physiol, 2008. 294(2): p. G411-7.
37. Mammen, J. M. and J. B. Matthews, Mucosal repair in the gastrointestinal tract. Crit Care Med, 2003. 31(8 Suppl): p. S532-7.
38. Andl, C. D., et al., Epidermal growth factor receptor mediates increased cell proliferation, migration, and aggregation in esophageal keratinocytes in vitro and in vivo. J Biol Chem, 2003. 278(3): p. 1824-30.
39. Getsios, S., et al., Desmoglein 1-dependent suppression of EGFR signaling promotes epidermal differentiation and morphogenesis. J Cell Biol, 2009. 185(7): p. 1243-58.
40. Casalino-Matsuda, S. M., M. E. Monzon, and R. M. Forteza, Epidermal growth factor receptor activation by epidermal growth factor mediates oxidant-induced goblet cell metaplasia in human airway epithelium. Am J Respir Cell Mol Biol, 2006. 34(5): p. 581-91.
41. Raufman, J. P., et al., Deoxycholyltaurine rescues human colon cancer cells from apoptosis by activating EGFR-dependent PI3K/Akt signaling. J Cell Physiol, 2008. 215(2): p. 538-49.
42. Banks-Schlegel, S. and H. Green, Involucrin synthesis and tissue assembly by keratinocytes in natural and cultured human epithelia. J Cell Biol, 1981. 90(3): p. 732-7.
43. Wilanowski, T., et al., Perturbed desmosomal cadherin expression in grainy head-like 1-null mice. EMBO J, 2008. 27(6): p. 886-97.
44. Tao, J. N., et al., BMP-dependent expression of Xenopus grainyhead-like 1 is essential for epidermal differentiation. Development, 2005. 132(5): p. 1021-1034.
45. Bergman, R., et al., Disadhesion of epidermal keratinocytes: a histologic clue to palmoplantar keratodermas caused by DSG1 mutations. J Am Acad Dermatol, 2010. 62(1): p. 107-13.
46. Taylor, J. M., et al., Dynamic and physical clustering of gene expression during epidermal barrier formation in differentiating keratinocytes. PLoS One, 2009. 4(10): p. e7651.